We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Wearable Sensor Could Reduce Catheter-Related Bloodstream Infections

By HospiMedica International staff writers
Posted on 27 Dec 2023

Hospitalized patients already face numerous challenges, and the risk of acquiring a catheter-related bloodstream infection only adds to their burden. More...

These infections, often life-threatening, can prolong hospital stays and escalate treatment costs. They commonly occur when a central venous catheter, or a central line, is placed in a large vein leading directly to the heart. These catheters are crucial for critically ill patients, enabling rapid medication administration or heart function monitoring.

In response to this critical issue, researchers at Texas A&M University (College Station, TX, USA) are pioneering a catheter dressing designed to reduce the frequency and severity of catheter-related bloodstream infections. This innovative dressing, integrated with the catheter, will incorporate wireless sensors capable of detecting extremely low levels of bacterial growth on the skin. Currently, no catheters in the market can automatically and swiftly detect bacterial growth at the catheter-insertion site. Previous attempts by other researchers to detect bacteria indirectly, such as through variations in skin pH, haven't addressed the need for direct bacteria detection.

Often, initial signs of infection might be overlooked because the dressing conceals symptoms like swelling or drainage. Any delay in detecting an infection provides time for it to escalate. Once an infection is suspected, healthcare providers must await blood test results to confirm its presence and might resort to broad-spectrum antibiotics while waiting, which can lead to antibiotic resistance.

The successful development of this dressing with embedded wearable sensors signifies a potential paradigm shift. It can alert healthcare providers to bacterial growth without the need to remove the dressing, leading to prompt and more accurate detection. This advancement could pave the way for immediate and targeted antibiotic treatments, reducing the prevalence of antibiotic resistance. Nonetheless, the research team faces several hurdles, including the challenge of detecting exceedingly low bacterial levels, ensuring the dressing's flexibility, incorporating a durable adhesive, and selecting materials that minimize allergic reactions in patients.

Related Links:
Texas A&M University


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Multifunctional Patient Floor Lift
Maxi Move 5
New
Tracheostomy Tube
Portex BLUselect
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.